| Date | Form | Description | Docs | XBRL | Pages |
| 04/26/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/24/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/22/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/13/19 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 01/25/19 | 8-K | Current report filing |
|
5 | |
| 01/11/19 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
95 |
| 01/10/19 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
5 | |
| 10/26/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 10/25/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 10/09/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
Latest News & Events
Anixa Biosciences to Present at the B. Riley Oncology Investor Conference
Read More...Anixa Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference
Read More...Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine
Read More...